To pace into our ultimate goal for developing OXY as a potential treating agent for psoriasis, we therefore focused mainly on exploring the anti-proliferative effects of OXY against TNF-α stimulation in keratinocyte, using HaCaT as a study model. This evidence concerns the gene GCG and psoriasis.